98
Kronik Hepatit B
infected patients. J Hepatol. 2005; 42(5): 615-24
8.
Benhamou Y, Bochet M, Thibault V, et al. Long-term incidence of hepatitis B virus
resistance to lamivudine in human immunodeficiency virus-infected patients.
Hepatology. 1999; 30(5): 1302-6.
9.
McMahon MA, Jilek BL, Brennan TP, et al. The HBV drug entecavir–effects on HIV-
1 replication and resistance. N Engl J Med. 2007; 356(25): 2614-21.
10.
T.C. Sağlık Bakanlığı HIV7AIDS Tanı Tedavi Rehberi 2013
11.
Castelnau C, Le Gal F, Ripault MP, Gordien E, Martinot- Peignoux M, Boyer N,
et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of
quantitative RT-PCR for follow-up. Hepatology 2006;44:728–735.
12.
Wedemeyer H, Yurdaydin C, Dalekos G, Erhardt A, Cakaloglu Y, Degertekin H, et
al. 72 week data of the HIDIT-1 trial: a multicenter randomised study comparing
peginterferon alpha-2a plus adefovir vs peginterferon alpha-2a plus placebo vs
adefovir in chronic delta hepatitis. J Hepatol 2007;46 (Suppl. 1):S4.
13.
EASL Clinical Practice Guidelines:Management of chronic hepatitis B virus
infection. Journal of Hepatology 2012;57;167-85
14.
Villa E, Grottola A, Buttafoco P, et al. High doses of alpha-interferon are required in
chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long
term results of a prospective randomized trial. Am J Gastroenterol. 2001; 96(10):
2973-7.
15.
Potthoff A, Jaroszewicz J, Manns MP, Wedemeyer H. Management of patients
coinfected with HBV and HCV. Hot Topics in Viral Hepatitis. 2010; 6(17):7-15.
16.
Liaw YF, Leung N, Kao JH, et al. Asian-Pacific consensus statement on the
management of chronic hepatitis B: a 2008 update. Hepatol Int. 2008; 2(3): 263-
83.
17.
Piratvisuth T. Optimal management of HBV infection during pregnancy. Liver Int.
2013; 33(Suppl. 1): 188-94.
18.
Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res.
2010; 40(1): 31-48.
19.
Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int. 2009;
29(1): 133-9.
20.
Buchanan C, Tran TT. Management of chronic hepatitis B in pregnancy. Clin Liver
Dis. 2010; 14(3): 495-504.
21.
Piratvisuth T. Optimal management of HBV infection during pregnancy. Liver Int.
2013; 33(Suppl. 1): 188-94.
22.
Celen MK, Mert D, Ay M, Dal T, Kaya S, Yildirim N, Gulsun S, Barcin T, Kalkanli S,
Ayaz C. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the
prevention of vertical transmission of HBV infection. World J Gastroenterol. 2013
Dec 28;19(48):9377-82.
23.
Ridruejo E, Adrover R, Alonso C, Mandó OG, Silva MO. Entecavir treatment for
chronic hepatitis B infection in end-stage renal disease and kidney transplantation.
Dial Transplant. 2010; 39(9): 397-400.
24.
Lok AS, McMahon BJ. AASLD practice guideline update. Chronic hepatitis B:
update 2009. Hepatology. 2009; 50(3): 661-2.
25.
Levitsky J, Doucette K; AST Infectious Diseases Community of Practice. Viral
hepatitis in solid organ transplantation. Am J Transplant. 2013; 13(Suppl. 4): 147-68.
26.
Evens AM, Jovanovic BD, Su YC, et al. Rituximab-associated hepatitis B virus (HBV)
reactivation in lymphoproliferative diseases: meta-analysis and examination of
FDA safety reports. Ann Oncol. 2011; 22(5): 1170-80.
